Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 176

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 176
---
.

In February 2024, Revium Ltd and Ms. Martin entered
into an employment agreement pursuant to which she is paid a monthly salary plus automobile related expenses in New Israeli Shekel equivalent
of approximately$4,000, payable on monthly basis. Ms. Martin’s Consulting Agreement continues in effect and her duties were allocated
on the basis of 70% to the Consulting Agreement and 30% to the employment agreement. Accordingly, the fee to which Ms. Martin is entitled
under the Consulting agreement was accordingly reduced, such that she continues to receive approximately the same compensation that she
was entitled to under the amended Consulting Agreement.

Under the employment agreement, Ms. Martin is
entitled to a leased automobile. Ms. Martin is also entitled to the following: (i) Manager’s Insurance under Israeli law to which
Revium Ltd. contributes amounts equal to (a) 8-1/3 percent for severance payments, and 6.5%, or up to 7.5% (including disability insurance)
designated for premium payment (and Ms. Martin contributes an additional 6%) of each monthly salary payment, and (b) 7.5% of his salary
(with Ms. Martin contributing an additional 2.5%) to an education fund, a form of deferred compensation program established under Israeli
law. Either we or Ms. Martin is entitled to terminate the employment relationship on 90 days prior written notice.

Ms. Martin was awarded stock options under the
Company’s 2021 Plan, as amended (the “2021 Plan”), on September 30, 2021 options to purchase 1,440,000 shares of the
Company’s Common Stock at a per share price of $0.40, which were fully vested as of December 31, 2023. In addition, on February
9, 2024 Ms. Martin was granted stock options to purchase 3,800,000 shares of the Company’s Common Stock at a per share price of
$0.001, of which 1,900,000 options were fully vested upon grant and the remaining 1,900,000 stock options are scheduled to vest on a
quarterly basis over two years in equal quarterly installments of 237,500 options, beginning with the quarter ended March 31, 2024. The
options are exercisable within eight years from grant date.

The agreements contain customary confidentiality
obligations which are not limited by the term of the agreement.